Overview Request Sample Pages Request Customization Download PDF
You are viewing: US Compression Therapy Market analysis
Part of: Compression Therapy Market (Global)

The US Compression Therapy Market was valued at $352.2 Million in 2025 and projected to reach to $486 Million by 2030, representing a compound annual growth rate of 6.7%. The US compression therapy market is positioned for sustained growth driven by an aging population with higher prevalence of venous and lymphatic disorders.

US Compression Therapy Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Compression Therapy Market Trends and Insights

  • The US market benefits from rising prevalence of chronic venous insufficiency, lymphedema, and sports-related injuries, alongside increasing adoption of compression garments in clinical and preventive care settings.
  • Healthcare providers across the US are integrating compression therapy into treatment protocols for post-surgical recovery and wound management, driving consistent market expansion. In the US, demand for compression therapy products is accelerating due to an aging population and growing awareness of non-pharmacological treatment options.
  • The US market is characterized by strong distribution networks, established reimbursement frameworks, and significant investment in product innovation.
  • Between 2025 and 2030, the US compression therapy sector will benefit from technological advances in fabric design, improved patient compliance, and expanded clinical evidence supporting therapeutic outcomes..

Key Market Statistics

  • CAGR (2025-2030) 6.7% CAGR
  • Market Size, 2025 ~USD 352.2 Million
  • Forecast, 2030 ~USD 486 Million
  • Country US

US Compression Therapy Market Overview

Market Size & Growth :

The US compression therapy market is valued at $352.2 million in 2025 and is projected to reach $486.0 million by 2030, representing a robust CAGR of 6.7%, outpacing the global growth rate of 5.5%.

Rising Chronic Disease Prevalence :

Increasing incidence of chronic venous insufficiency, lymphedema, and diabetic complications in the US population is driving demand for compression therapy solutions across clinical and home care settings.

Sports & Preventive Care Adoption :

Growing consumer awareness of compression garments for injury prevention and athletic recovery is expanding the market beyond clinical applications into the wellness and sports medicine segments.

Healthcare Infrastructure Support :

Strong US healthcare reimbursement policies, advanced medical device regulations, and established distribution networks are facilitating market penetration and product innovation in compression therapy.

US Compression Therapy Market Dynamics

  • Increasing healthcare spending on preventive care and rehabilitation, combined with rising adoption among athletes and fitness enthusiasts, will expand the addressable market beyond traditional clinical settings.
  • Technological advancements in fabric engineering and smart compression devices are expected to enhance product efficacy and consumer appeal.
  • The market will benefit from improved insurance coverage and clinical evidence supporting compression therapy outcomes.
  • By 2030, the market is anticipated to capture growing demand from both institutional healthcare providers and direct-to-consumer channels, solidifying the US as a key growth driver for the global compression therapy industry..

Related Ecosystem

Medical Devices

Top Technologies
    Top Companies

      Key Takeaways

      • The US compression therapy market will grow from $352.2M (2025) to $486.0M (2030) at a 6.7% CAGR, outpacing global growth.
      • Rising prevalence of venous and lymphatic disorders in the US population is a primary driver of market expansion.
      • The US market benefits from established reimbursement policies and strong healthcare infrastructure supporting compression therapy adoption.
      • Technological innovation in compression garment design and materials will accelerate US market growth through 2030.

      Compression Therapy Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment LYMPHEDEMA TREATMENT (Application)
      Forecast Period 2025–2030
      Growth Rate CAGR of 5.5% from 2025 to 2030
      Largest Segment STATIC COMPRESSION THERAPY (Technique)
      Market Size Base Year (Billions) ~USD 4.51 (2025)
      Revenue Forecast (Billions) ~USD 5.9 (2030)
      Segments Covered Product, Technique, Application, Distribution Channel, Type

      US Compression Therapy Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Product

      • Compression Bandages
      • Compression Braces
      • Compression Stockings
      • Compression Tapes
      • Compression Wraps
      • Other Compression Garments
      • Pneumatic Compression Devices

      By Technique

      • Dynamic Compression Therapy
      • Static Compression Therapy

      By Application

      • Deep Vein Thrombosis Treatment
      • Leg Ulcer Treatment
      • Lymphedema Treatment
      • Other Applications
      • Varicose Vein Treatment

      By Distribution Channel

      • E-Commerce Platforms
      • Home Care Settings
      • Hospitals & Clinics
      • Pharmacies & Retailers

      By Type

      • Class I
      • Class Ii
      • Class Iii
      • Intermittent Compression Devices
      • Sequential Compression Devices

      Target Audience

      • Medical Device Manufacturers : Compression therapy product developers and manufacturers need US market data to assess market opportunity, competitive positioning, and growth potential for product launches and expansion strategies.
      • Healthcare Providers & Hospitals : US hospitals, clinics, and rehabilitation centers require market insights to understand demand trends, procurement opportunities, and clinical adoption patterns for compression therapy solutions.
      • Insurance & Reimbursement Companies : Payers and insurance providers need comprehensive US market analysis to evaluate coverage policies, cost-effectiveness, and reimbursement strategies for compression therapy treatments.
      • Investors & Private Equity Firms : Investment professionals targeting the US healthcare sector require detailed market forecasts and growth drivers to identify attractive investment opportunities in compression therapy companies.
      • Retail & E-commerce Distributors : Direct-to-consumer retailers and online platforms need US market segmentation data to understand consumer demand, pricing strategies, and distribution channel opportunities in compression wear.

      Key Companies in the US Compression Therapy Market

      CompanyHQOwnershipStrongest segments
      DEVON MEDICAL PRODUCTSUnited StatesPrivate CompanyPneumatic compression (dynamic),Stockings (static),Wraps and bandages (static),
      KINDRED HEALTHCARE INC.United StatesPrivate CompanyBandage,Wraps,Stockings,
      BEIERSDORF AGGermanyPublic CompanyBandages,Wraps,Stockings,
      SOLVENTUM CORPORATION (3M)United States
      ENOVIS CORPORATIONUnited StatesPublic CompanyStatic compression (bandages, wraps, stockings, tapes),Braces with integrated compression,Dynamic/pneumatic compression systems,
      BSN MEDICAL (A SUBSIDIARY OF ESSITY)Sweden
      CARDINAL HEALTHUnited StatesPublic CompanyBandages & Wraps,Stockings,Tapes,
      TACTILE MEDICALUnited StatesPublic CompanyPneumatic compression systems (Flexitouch Plus, Entre Plus, Nimbl),Software and digital engagement (Kylee app, connectivity, services),Non-compression respiratory therapy (AffloVest),
      CONVATEC INC.United KingdomPublic CompanyStatic compression (bandages, wraps, stockings, tapes, braces),Dynamic compression (pneumatic devices),
      MEDI GMBH & CO. KGTaiwanPublic CompanyStockings (Static),Wraps & Braces (Static),Bandages & Tapes (Static),
      PAUL HARTMANNGermanyPublic CompanyBandages (compression, universal, zinc paste, padding),Wraps and Stockings,Tapes and Braces,
      SMITH+NEPHEWUnited KingdomPublic CompanyBandage,Wraps,Stockings,

      DEVON MEDICAL PRODUCTS

      Devon Medical Products is a private medical products company founded in 2005 and based in the United States.

      KINDRED HEALTHCARE INC.

      Kindred Healthcare Inc. is a private healthcare company founded in 1985 in the United States with 64,200 employees.

      BEIERSDORF AG

      Beiersdorf AG is a German public company founded in 1882 with 21,589 employees, operating in the healthcare and consumer goods sectors.

      SOLVENTUM CORPORATION (3M)

      Insufficient data available to provide a business description for Solventum Corporation (3M).

      ENOVIS CORPORATION

      Enovis Corporation is a public medical technology company founded in 1995 in the United States with 7,802 employees.

      BSN MEDICAL (A SUBSIDIARY OF ESSITY)

      Insufficient data available to provide a business description for BSN Medical (a subsidiary of Essity).

      CARDINAL HEALTH

      Cardinal Health is a public healthcare services and pharmaceutical distribution company founded in 1979 in the United States with 55,392 employees.

      TACTILE MEDICAL

      Tactile Medical is a public medical device company founded in 1995 in the United States with 1,086 employees.

      CONVATEC INC.

      ConvaTec Inc. is a public medical products and healthcare company founded in 1978 in the United Kingdom with 10,910 employees.

      MEDI GMBH & CO. KG

      Medi GmbH & Co. KG is a public medical device company founded in 1997 based in Taiwan with 17,449 employees.

      PAUL HARTMANN

      Paul Hartmann is a German public healthcare company founded in 1818 with 10,066 employees.

      SMITH+NEPHEW

      Smith+Nephew is a public medical devices and healthcare company founded in 1856 in the United Kingdom with 16,988 employees.

      Reasons to Buy this Report

      • US-Specific Market Sizing : Obtain precise valuation data for the US market ($352.2M in 2025) with detailed forecasts through 2030, enabling accurate budgeting and investment decisions tailored to the American healthcare landscape.
      • Competitive Landscape Intelligence : Understand the competitive dynamics, market share distribution, and key players operating in the US compression therapy sector to identify partnership and acquisition opportunities.
      • Regulatory & Reimbursement Insights : Access comprehensive analysis of US FDA regulations, insurance coverage policies, and reimbursement trends that directly impact market accessibility and revenue potential for compression therapy products.
      • Segment-Specific Growth Drivers : Identify high-growth segments within the US market including chronic disease management, sports medicine, and preventive care, with actionable insights for product development and marketing strategies.
      • Strategic Market Entry Planning : Leverage detailed US market analysis to develop go-to-market strategies, distribution channel optimization, and customer acquisition plans specific to American healthcare providers and consumers.

      Frequently asked questions

      What is the current size of the US compression therapy market?

      The US compression therapy market is valued at $352.2 million in 2025 and is expected to reach $486.0 million by 2030.

      What is the growth rate of the US compression therapy market?

      The US compression therapy market is projected to grow at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2030.

      What are the main drivers of growth in the US compression therapy market?

      Key drivers include rising prevalence of chronic venous insufficiency and lymphedema, an aging population, increased adoption in clinical settings, and growing awareness of non-pharmacological treatment options in the US.

      How does the US compression therapy market compare to global trends?

      The US market grows at 6.7% CAGR, exceeding the global average of 5.5%, reflecting strong healthcare infrastructure and reimbursement support in the US.

      What factors will influence the US compression therapy market through 2030?

      Technological advances in fabric design, expanded clinical evidence, improved patient compliance, and integration into post-surgical care protocols will drive US market growth through 2030.

      RESEARCH METHODOLOGY

      The size of the compression therapy market was based on four primary studies to ensure accuracy. Initial data for the compression therapy market and related sectors was gathered from 3 to 5 secondary sources. This information was then validated through primary research to confirm the assumptions and overall market sizing. Both top-down and bottom-up approaches were employed to determine the total market size, which was subsequently refined into segment and subsegment sizes. Finally, data triangulation was conducted to verify the accuracy of the findings.

      Secondary Research

      Secondary research sources included directories, Factiva, white papers, Bloomberg Business, annual reports, SEC filings, business filings, and investor presentations. These sources offered valuable insights into market leaders, sector divisions, and technological differences within various segments of the compression therapy industry.

      Primary Research

      Primary research consisted of both quantitative and qualitative insights gathered through interviews with key stakeholders. On the demand side, participants included physicians, researchers, department heads, and staff from diagnostic centers, hospitals, and research institutes. On the supply side, interviews were conducted with CEOs, area sales managers, territory and regional sales managers, and other top executives from relevant companies. These direct conversations helped validate the findings from secondary research and provided an opportunity to directly question and confirm assumptions.

      A breakdown of the primary respondents is provided below.

      Compression Therapy Market

      Note q: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

      Note 2: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      This report utilized the revenue share analysis of major companies to evaluate the size of the global compression therapy market. This analysis involved identifying key market participants and calculating their revenue from compression therapy using a variety of data collected during both primary and secondary research phases. One aspect of the secondary research included reviewing the annual and financial reports of leading market players. Conversely, primary research consisted of detailed interviews with influential thought leaders, including directors, CEOs, and key marketing executives.

      To determine the overall market value, the segmental revenue was calculated by mapping the revenue of the leading solution and service providers. The process involved several steps.

      • Making a list of leading international companies in the compression therapy industry
      • Charting annual profits made by leading companies in the compression therapy sector (or the closest stated business unit/product category)
      • 2024 revenue mapping of leading companies to cover a significant portion of the global market
      • Calculating the global value of the compression therapy industry

      Global Compression Therapy Market: Bottom-up and Top-down Approach

      Compression Therapy Market

      Data Triangulation

      To ensure accurate data, the compression therapy market was divided into various segments and subsegments. A data triangulation process that used both top-down and bottom-up approaches was applied. This involved analyzing factors and trends from both the demand and supply sides to validate the findings for each segment. The combination of this segmentation with the triangulation process helps ensure that the market data is both accurate and reliable.

      Market Definition

      Compression therapy is the process of applying controlled pressure to the lower extremities to increase and improve blood flow to the heart. This mode of treatment utilizes the elastic properties of compression garments or the pneumatic force of compression devices to address specific clinical requirements as part of disease management. The compression therapy market is primarily used for managing venous disorders, lymphedema, wound care, post-surgical recovery, and sports injuries. It enhances blood circulation, reduces swelling, and promotes healing, commonly through compression garments, bandages, and devices like pneumatic pumps. Key settings include hospitals, clinics, and home care.

      Stakeholders

      • Manufacturers of compression garments, bandages, and devices
      • Healthcare providers such as hospitals, clinics, and rehabilitation centers
      • Patients using compression therapy for various conditions
      • Healthcare professionals, including physicians, surgeons, and physiotherapists
      • Insurance companies involved in reimbursement and coverage
      • Regulatory bodies overseeing product standards and safety
      • Suppliers and distributors of compression therapy products
      • Research & development firms focusing on innovation and technology in compression therapy

      Report Objectives

      • To define, describe, and forecast the compression therapy market based on product, application, technique, distribution channel, and region
      • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
      • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the total market
      • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the revenue of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile the key players and comprehensively analyze their market ranking and core competencies
      • To benchmark players within the market using a proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy excellence and strength of product portfolio
      • To analyze competitive developments such as product launches, agreements, expansions, collaborations, and acquisitions in the compression therapy market

      Get the Full Compression Therapy Market Report

      Full forecast, segment splits, and company analysis for all Compression Therapy Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status